STRYKER

2017 Proxy Statement

Issue link: http://catalog.e-digitaleditions.com/i/801297

Contents of this Issue

Navigation

Page 28 of 69

25 The grant date fair value of the NEOs' 2016 performance stock unit awards, if earned at maximum levels (200% of target), was $8,120,718, $1,928,646, $2,943,785, $2,537,651 and $2,131,909 for Mr. Lobo, Mr. Boehnlein, Mr. Scannell, Mr. Floyd and Mr. Carpenter, respectively. Option Awards: This column represents the aggregate grant date fair value of stock option awards calculated in accordance with the Compensation — Stock Compensation Topic of the FASB Codification. Stock option values are derived using the Black-Scholes option pricing model assumptions that are discussed under "Grant Date Fair Value of Stock and Option Awards" on page 27. Non-Equity Incentive Plan Compensation: This column reflects the non-discretionary bonus plan amounts earned by the NEOs during the reported year and paid in February of the following year under our Executive Bonus Plan. This column also includes any portion of such payments that each NEO deferred into the 401(k) Plan and Supplemental Plan. All Other Compensation: This column includes the following items for 2016: • 401(k) Plan matching contributions and discretionary contributions made in March 2017 pertaining to the 2016 Plan year, in the amount of $27,550 for each NEO. • Stryker Supplemental Plan matching contributions and discretionary contributions made in March 2017 pertaining to the 2016 Plan year, in the amounts of $308,718, $63,840, $118,645, $80,835, $66,395 and $86,790 for Mr. Lobo, Mr. Boehnlein, Mr. Scannell, Mr. Floyd, Mr. Carpenter and Mr. Jellison, respectively. • In accordance with SEC disclosure requirements, perquisites and personal benefits received by any NEO must be identified by type if the total value was $10,000 or more. Mr. Floyd is the only NEO for whom perquisites and personal benefits exceeded $10,000 in 2016. These benefits for Mr. Floyd include costs associated with an executive physical examination and a personal benefit attributed to certain meeting expenses associated with attending and presenting at an Orthopaedics sales force meeting in 2016 and costs associated with his spouse's attendance at that meeting. The Compensation Committee has directed that the Company avoid the use of tax gross-ups on perquisites and personal benefits for NEOs except for relocation expenses and items related to expatriate assignments and in isolated cases where particular circumstances warrant. In 2016, none of the NEOs received tax gross-ups. Primary Compensation Elements: The following table indicates the percentages of our three primary compensation elements of salary, actual bonus and stock awards consisting of performance stock units (excluding the adjustment related to the 2013 PSUs) and stock options, in relation to the total of such elements for each NEO other than Mr. Jellison: Name Salary Bonus Plan Payment Performance Stock Units Grant Date Value (1) Stock Option Grant Date Value using Black-Scholes (1) Kevin A. Lobo 10 % 20% 37% 33% Glenn S. Boehnlein 18 % 19% 33% 30% Timothy J. Scannell 15 % 18% 35% 32% David K. Floyd 16 % 17% 35% 32% Lonny J. Carpenter 16 % 19% 34% 31% ______________ (1) Uses aggregate grant date fair value in accordance with the Compensation — Stock Compensation Topic of the FASB Codification for 2016 awards of performance stock units and stock option grants. See "Grant Date Fair Value of Stock and Option Awards" on page 27.

Articles in this issue

view archives of STRYKER - 2017 Proxy Statement